↓ Skip to main content

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer

Overview of attention for article published in Cochrane database of systematic reviews, October 2001
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
111 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer
Published in
Cochrane database of systematic reviews, October 2001
DOI 10.1002/14651858.cd003506
Pubmed ID
Authors

Timothy J Wilt, Bijay Nair, Roderick MacDonald, Indy Rutks

Abstract

Prostate cancer is a leading cause of cancer death in men. Treatment goals for men with advanced prostate cancer include prolonging survival, preventing or delaying symptoms due to disease progression, improving and maintaining quality of life, reducing treatment related morbidity. Androgen suppression therapy is considered a mainstay of treatment for men with advanced prostate cancer. However it is not clear whether early androgen suppression for men with locally advanced disease or asymptomatic metastases improves length and quality of life compared to androgen suppression deferred until signs and symptoms of clinical progression.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 2%
United Kingdom 2 2%
Italy 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 104 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 15%
Other 14 13%
Student > Ph. D. Student 14 13%
Researcher 12 11%
Student > Doctoral Student 11 10%
Other 25 23%
Unknown 18 16%
Readers by discipline Count As %
Medicine and Dentistry 58 52%
Nursing and Health Professions 4 4%
Agricultural and Biological Sciences 3 3%
Computer Science 2 2%
Decision Sciences 2 2%
Other 9 8%
Unknown 33 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2021.
All research outputs
#8,571,053
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#9,070
of 11,499 outputs
Outputs of similar age
#15,639
of 45,762 outputs
Outputs of similar age from Cochrane database of systematic reviews
#13
of 24 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 45,762 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.